Delta
"Back To Barter" In Another Warrant Deal
They
scored big once, and they're looking to do it again! That
succinctly is the story on Delta Air Lines' recent agreement
to post more fares and routes through Cheap Tickets in
exchange for an equity warrant in the seller of discounted
travel.
(Delta
first scored in a similar arrangement with Priceline.com--at
one time holding warrants that had a greater value than
Delta Air Lines! Subsequently, Delta earned over $500
million when it sold the stock about a year ago.)
"We're
both in a capital-strained industry. It's very useful
to barter like this."
--George
Holland, VP Marketing
Broadview Networks Holding
NUI
Corp. which owns telecommunications and utility companies,
said its NUI Telecom unit and Broadview Networks Holdings
have agreed to share phone lines and marketing departments
so each can gain revenue through a barter arrangement.
NUI
Telecom will offer high-speed internet access through
Broadview Networks' digital subscriber line, or DSL, service.
Broadview, a New York-based company offering local phone
service in the northeast, will use NUI Telecom's marketing
department to attract new customers.
Revenue
from the agreement could net NUI Telecom as much as $25
million and Broadview could gain $17 million, the companies
said in a statement. The companies are non-competitive,
with closely held Broadview selling local phone service
and NUI concentrating on heavy long-distance users.
Drug
Companies Continually "Barter" For Doctors'
Attention
The
ubiquitous ads on TV, which advertise everything under
the sun from the drug companies to consumers, amount to
$2.5 billion a year. Far more staggering, however, is
the $4.04 billion the industry barters to get the attention
of the physicians!
Yes,
wooing doctors--by providing them everything from gourmet
meals, to Christmas trees, Valentine's Day flowers, books,
CDs, manicures, pedicures, car washes, bottles of wine,
free gasoline, and various trips --is a proven way to
get their attention, so as to inform them about a particular
new drug.
The
AMA (American Medical Association) says such items are
of minimal value and permissible, as long as they are
related to the physician's work and primarily entail a
benefit to patients.